ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 141,46
-0,67%
Dow Jones
39 872,99
0,17%
DAX
18 726,76
-0,21%
Brent Oil
82,255
-0,23%
Bitcoin
69 761,81
-0,53%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Lannett Company Inc (LCI)

  7. Lannett Company Inc (LCI) Actualités

LCI

Lannett (LCI)

Lannett Company Inc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:LCI
DateHeureSourceTitreSymboleSociété
26/06/202312h03Edgar (US Regulatory)Notice of Effectiveness (effect)NYSE:LCILannett Company Inc
20/06/202312h53Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NYSE:LCILannett Company Inc
20/06/202312h52Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NYSE:LCILannett Company Inc
20/06/202312h48Edgar (US Regulatory)Current Report Filing (8-k)NYSE:LCILannett Company Inc
15/05/202322h32Edgar (US Regulatory)Quarterly Report (10-q)NYSE:LCILannett Company Inc
04/05/202316h20Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NYSE:LCILannett Company Inc
01/05/202312h55PR Newswire (US)Lannett Company, Inc. Enters Into Restructuring Support AgreementNYSE:LCILannett Company Inc
20/04/202312h53PR Newswire (US)NYSE TO SUSPEND TRADING IMMEDIATELY IN LANNETT COMPANY, INC. (LCI) AND COMMENCE DELISTING PROCEEDINGSNYSE:LCILannett Company Inc
04/04/202312h55PR Newswire (US)LANNETT SHARES UPDATENYSE:LCILannett Company Inc
10/02/202315h47Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:LCILannett Company Inc
01/02/202322h15PR Newswire (US)LANNETT REPORTS IMPROVED FISCAL 2023 SECOND QUARTER FINANCIAL RESULTS; RAISES FULL-YEAR GUIDANCENYSE:LCILannett Company Inc
25/01/202322h30PR Newswire (US)LANNETT ANNOUNCES 1 FOR 4 REVERSE STOCK SPLITNYSE:LCILannett Company Inc
25/01/202312h52PR Newswire (US)LANNETT TO REPORT FISCAL 2023 SECOND-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, FEBRUARY 1NYSE:LCILannett Company Inc
04/01/202312h52PR Newswire (US)LANNETT PROVIDES DEVELOPMENT UPDATE ON BIOSIMILAR INSULIN PRODUCTSNYSE:LCILannett Company Inc
18/11/202222h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:LCILannett Company Inc
10/11/202222h14Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NYSE:LCILannett Company Inc
07/11/202212h52PR Newswire (US)LANNETT ANNOUNCES PATENT LICENSES FOR THE PEN INJECTOR DELIVERY DEVICE TO BE USED FOR ITS INSULIN GLARGINE AND INSULIN ASPART DEVELOPMENT PROGRAMNYSE:LCILannett Company Inc
02/11/202221h15PR Newswire (US)LANNETT REPORTS BETTER THAN EXPECTED FINANCIAL RESULTS FOR FISCAL 2023 FIRST-QUARTER; REITERATES FULL-YEAR GUIDANCENYSE:LCILannett Company Inc
26/10/202212h52PR Newswire (US)LANNETT TO REPORT FISCAL 2023 FIRST-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, NOVEMBER 2NYSE:LCILannett Company Inc
21/10/202212h53PR Newswire (US)LANNETT RECEIVES FDA APPROVAL TO MANUFACTURE NUMBRINO® AT SEYMOUR PLANTNYSE:LCILannett Company Inc
19/10/202212h55PR Newswire (US)LANNETT ANNOUNCES SALE OF SEVERAL DISCONTINUED GENERIC DRUGSNYSE:LCILannett Company Inc
31/08/202212h53PR Newswire (US)LANNETT ANNOUNCES SUBJECT DOSING COMPLETE FOR PIVOTAL CLINICAL TRIAL OF BIOSIMILAR INSULIN GLARGINENYSE:LCILannett Company Inc
25/08/202214h11Edgar (US Regulatory)Annual Report (10-k)NYSE:LCILannett Company Inc
24/08/202222h15PR Newswire (US)LANNETT REPORTS FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTSNYSE:LCILannett Company Inc
19/08/202212h52PR Newswire (US)LANNETT TO REPORT FISCAL 2022 FOURTH-QUARTER, FULL-YEAR FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, AUGUST 24NYSE:LCILannett Company Inc
01/06/202212h52PR Newswire (US)LANNETT PROVIDES UPDATE ON PIVOTAL CLINICAL TRIAL FOR BIOSIMILAR INSULIN GLARGINENYSE:LCILannett Company Inc
12/05/202212h52PR Newswire (US)LANNETT ENTERS AGREEMENT TO BE EXCLUSIVE U.S. DISTRIBUTOR OF FLUDARABINE PHOSPATE FOR INJECTION, USPNYSE:LCILannett Company Inc
04/05/202222h15PR Newswire (US)LANNETT REPORTS FISCAL 2022 THIRD-QUARTER FINANCIAL RESULTSNYSE:LCILannett Company Inc
27/04/202212h52PR Newswire (US)LANNETT TO REPORT FISCAL 2022 THIRD-QUARTER FINANCIAL RESULTS, HOST CONFERENCE CALL ON WEDNESDAY, MAY 4NYSE:LCILannett Company Inc
29/03/202212h52PR Newswire (US)LANNETT INITIATES PIVOTAL CLINICAL TRIAL FOR BIOSIMILAR INSULIN GLARGINENYSE:LCILannett Company Inc
 Showing the most relevant articles for your search:NYSE:LCI

Dernières Valeurs Consultées

LSE
FG99
Citi Fun 25
LSE
10OK
BOV
TAKP34R
Takeda Pharmaceutical
GDAX
XTZEUR
Tezos
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés